drugset / Trial / NCT00813098
Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability, and effectiveness of LX1031 versus a placebo control in subjects with non-constipating irritable bowel syndrome.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-07
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LX1031 | Unknown | — | Oral |